Prof. Dr. HACI MEHMET TÜRK

Yayın Ağı

Makaleler 44

1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

Sucuoğlu İşleyen Z., Seçmeler Ş., Sakin A., Cihan Ş., Beşiroğlu M., Kahraman S., et al.

BMC Cancer , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Birinci basamakta hedefe yönelik ajanlarla tedavi edilen RAS mutasyonu taşımayan metastatik kolorektal kanser hastalarında gerçek yaşam verileri: Ulusal onco-colon Türkiye kayıt sistemi

TATLIDEDE D., Arslan C., YILDIRIM M. E., Işıkdoğan A., Karadurmuş N., Karabulut B., et al.

ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ , cilt.31, sa.1, ss.42-51, 2026 (TRDizin)

3. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

Uysal M., Saglam S., Beypınar İ., Saglam E. K., Mammadov E., Ocak B., et al.

Cancer Investigation , cilt.44, sa.2, ss.127-135, 2026 (SCI-Expanded, Scopus)

4. Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Okten I. N., Baydas T., Yildirim M. E., Bilir C., YALÇIN Ş., ÇUBUKÇU E., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.15, sa.2, 2026 (SCI-Expanded, Scopus)

5. Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program

ŞENDUR M. A. N., Hizal M., Cakar B., AKTEPE O. H., Eraslan E., ARIK Z., et al.

BMC CANCER , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

6. Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors

Sucuoğlu İşleyen Z., MUĞLU H., Alaca Topçu Z., Beşiroğlu M., Yasin A. İ., Topçu A., et al.

Medicina (Lithuania) , cilt.61, sa.7, 2025 (SCI-Expanded, Scopus)

7. Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death-ligand 1 ≥50%

Kilickap S., ÖZGÜROĞLU M., Sezer A., Gümüş M., Bondarenko I., Gogishvili M., et al.

Cancer , cilt.131, sa.10, 2025 (SCI-Expanded, Scopus)

8. Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study

Ceylan F., Aktürk Esen S., Ünal O. Ü., Aslan F., Onur İ. D., Ateş Ö., et al.

Medicina (Lithuania) , cilt.61, sa.5, 2025 (SCI-Expanded, Scopus)

9. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Yildirim M. E., Karadurmus N., Okten I. N., TÜRK H. M., Urakci Z., Arslan C., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.31, sa.3, ss.404-411, 2025 (SCI-Expanded, Scopus)

10. Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis

Kalkan N., Ucar G., Esen S., Bardakci M., Aydin S., Celebi A., et al.

NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.28, sa.2, ss.212-218, 2025 (SCI-Expanded, Scopus)

11. New targets and strategies in treatment of metastatic gastric cancer

Simsek M., TÜRK H. M.

Future Oncology , cilt.21, sa.22, ss.2931-2940, 2025 (SCI-Expanded, Scopus)

12. Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

Kahraman S., Karakaya S., Kaplan M. A., SEZGİN GÖKSU S., Ozturk A., Isleyen Z. S., et al.

Scientific Reports , cilt.14, sa.1, 2024 (SCI-Expanded, Scopus)

13. Assessment of cyclin D1 activity in tumors and tumor budding and its prognostic significance in tumor budding in colorectal carcinomas.

Coban G., Arici D. S., Tekden B. C., Yildiz P., Kiran T., Toluk Ö., et al.

Indian journal of pathology & microbiology , cilt.67, sa.4, ss.753-757, 2024 (SCI-Expanded, Scopus)

14. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

Yasin A. I., ULUGANYAN M., Isleyen Z. S., Topcu A., Shbair A. T., ŞİMŞEK M., et al.

Supportive Care in Cancer , cilt.32, sa.8, 2024 (SCI-Expanded, Scopus)

15. Pretreatment HALP Score Predicts Prognosis in Patients with Esophageal Cancer Treated with Chemoradiotherapy

İŞLEYEN Z. S., BEŞİROĞLU M., ŞİMŞEK M., YASİN A. İ., TOPÇU A., AKÇAKAYA A., et al.

Eurasian Journal of Medical Investigation , cilt.8, sa.2, ss.113-118, 2024 (TRDizin)

16. A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

GÜRLER F., Tay F., Sucuoğlu İşleyen Z., Yerlikaya T., Hendem E., Esen S. A., et al.

Cancer Medicine , cilt.13, sa.14, 2024 (SCI-Expanded, Scopus)

17. Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.

Wainberg Z. A., Kang Y., Lee K., Qin S., Yamaguchi K., Kim I., et al.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association , cilt.27, sa.3, ss.558-570, 2024 (SCI-Expanded, Scopus)

18. Promising outcome of patients with recurrent glioblastoma after Gamma Knife-based hypofractionated radiotherapy

HATİBOĞLU M. A., Akdur K., Sakarcan A., SEYİTHANOĞLU M. H., TÜRK H. M., Sinclair G., et al.

Neurochirurgie , cilt.70, sa.2, 2024 (SCI-Expanded, Scopus)

19. Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients.

Topcu A., Yasin A. I., Besiroglu M., Sucuoglu Isleyen Z., Alaca Topcu Z., Simsek M., et al.

Frontiers in medicine , cilt.11, ss.1331246, 2024 (SCI-Expanded, Scopus)

20. Local interventions for colorectal cancer metastases to liver and lung

ŞİMŞEK M., Besiroglu M., AKÇAKAYA A., Topcu A., Yasin A. I., Isleyen Z. S., et al.

Irish Journal of Medical Science , cilt.192, sa.6, ss.2635-2641, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks

Gultekin M. A., Peker A. A., Oktay A. B., Turk H. M., Cesme D. H., Shbair A. T. M., et al.

JOURNAL OF CLINICAL ULTRASOUND , cilt.51, sa.9, ss.1579-1586, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. The risk of malnutrition and its clinical implications in older patients with cancer.

Sucuoglu Isleyen Z., Besiroglu M., Yasin A. I., Simsek M., Topcu A., Smith L., et al.

Aging clinical and experimental research , cilt.35, sa.11, ss.2675-2683, 2023 (SCI-Expanded, Scopus)

23. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Shah M. A., Shitara K., Ajani J. A., Bang Y., Enzinger P., Ilson D., et al.

Nature Medicine , cilt.29, sa.8, ss.2133-2141, 2023 (SCI-Expanded, Scopus)

24. Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

Tsuboi M., Herbst R. S., John T., Kato T., Majem M., Grohé C., et al.

The New England journal of medicine , cilt.389, sa.2, ss.137-147, 2023 (SCI-Expanded, Scopus)

25. Stem cell markers: A guide to neoadjuvant therapy inbreast carcinomas

Gücin Z., Büyükpınarbaşılı N., Geçer M., Ersoy Y. E., Türk H. M., Yıldız Ş., et al.

INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY , cilt.66, ss.495-501, 2023 (SCI-Expanded, Scopus)

26. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.29, sa.5, ss.1178-1186, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. The correlation between skeletal muscle index and anxiety in patients with lung cancer on the first day of chemotherapy.

Topcu A., Yurtsever İ., Isleyen Z. S., Besiroglu M., Yasin A. I., Topcu Z. A., et al.

Future oncology (London, England) , cilt.19, sa.16, ss.1139-1149, 2023 (SCI-Expanded, Scopus)

28. The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study

Baydas T., ÇOBAN G., Besiroglu M., ŞİMŞEK M., Shbair A. T., Topcu A., et al.

International Journal of Gastrointestinal Intervention , cilt.12, sa.2, ss.69-74, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma

29. Second-line Therapy after Trastuzumab Failure in HER2- Positive Metastatic Gastric Cancer: A Real-life Data

Topçu A., Beşiroğlu M., Atçı M. M., Secmeler Ş., Ayhan M., Özkan M., et al.

Eurasian Journal of Medical Investigation , cilt.7, sa.2, ss.153-161, 2023 (TRDizin) Sürdürülebilir Kalkınma

30. Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.

Wainberg Z. A., Enzinger P. C., Kang Y., Qin S., Yamaguchi K., Kim I., et al.

The Lancet. Oncology , cilt.23, ss.1430-1440, 2022 (SCI-Expanded, Scopus)

31. The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma.

Topcu A., Ozturk A., Yurtsever İ., Besiroglu M., Yasin A. I., Turk H. M., et al.

Bosnian journal of basic medical sciences , cilt.22, sa.6, ss.982-991, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer

ŞİMŞEK M., Yasin A., BEŞİROĞLU M., TOPÇU A., SUCUOĞLU İŞLEYEN Z., ŞEKER M., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.9, ss.4138-4143, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study.

Simsek M., Aliyev A., Baydas T., Besiroglu M., Demir T., Shbair A. T., et al.

The breast journal , cilt.2022, ss.5763810, 2022 (SCI-Expanded, Scopus)

34. Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer.

Bilgin S. S., Gultekin M. A., Yurtsever İ., Yilmaz T. F., Cesme D. H., Bilgin M., et al.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine , cilt.21, sa.3, ss.425-431, 2022 (SCI-Expanded, Scopus)